We first reported data from the results of the RTOG 0938 trial in January 2016 when they were presented at the Genitourinary Cancers Symposium in that year. These results have now been formally published, and there are some changes to the data on publication, so Allen Edel has provided an update. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, hypofractionated, radiation, SBRT, stereotactic, toxicity | Leave a comment »
In several randomized clinical trials of external beam treatment of primary prostate cancer, we have seen that moderately hypofractionated intensity-modulated radiation therapy (HypoIMRT), accomplished in 12 to 26 treatments or fractions, is no worse than conventionally fractionated IMRT treatment (in 40 to 44 fractions). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypofractionated, IMRT, life, quality, radiation, SBRT, stereotactic | 3 Comments »
There has been some question as to whether the toxicity of delivering very high doses of external beam radiation per treatment (or fraction) in fewer fractions (called “extreme hypofractionation” or SBRT) would be high compared to conventional dose rates per fraction. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk, Treatment | Tagged: 3D-CRT, extreme, hypofractionated, outcome, radiation, SBRT, stereotactic | Leave a comment »
Data reported at the recent Genitourinary Cancers Symposium have shown that the toxicities associated with stereotactic body radiation therapy (SBRT) are acceptable and similar whether the radiation is give as 5 or 12 doses. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionated, radiation, SBRT, stereotactic, toxicity | 2 Comments »
The largest-yet randomized clinical trial comparing hypofractionated (fewer treatments or fractions) to normally fractionated intensity-modulated radiation therapy (IMRT) has proved that oncological outcomes and late-term toxicities were the same for both treatment schedules. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypofractionated, IMRT, outcome, radiation, therapy, trial | 15 Comments »
In a previous article, we looked at the experimental use of extreme hypofractionated radiation therapy (SBRT or SABR) to treat high-risk patients. Here, we take a closer look at an early (Phase I/II) safety study by Bauman et al. that shows why radiation safety is more complicated than just setting the treatment dose. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: hypofractionated, radiation, SABR, safety, SBRT | 1 Comment »
Many readers may be interested in reading an editorial just published in the Journal of Clinical Oncology that deals with “hypofractionation” (giving fewer doses of radiation therapy at higher dose levels) in treatment of localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: conventional, hypofractionated, IMRT, radiation | Leave a comment »
Advocates for proton beam radiation therapy (PBRT) are not going to be enamored of the article in the Wall Street Journal (WSJ) on the cost/benefit ratio of this form of treatment for localized prostate cancer. …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: benefit, cost, hypofractionated, PBRT, proton, radiation | 7 Comments »
A report to be presented at the upcoming meeting of the American Society for Radiation Oncology (ASTRO) offers 5-year outcome data from a trial comparing conventional intensity-modulated radiation therapy (IMRT) to the more recently developed hypofractionated IMRT for men with localized prostate cancer. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: comparison, conventional, hypofractionated, IMRT, intensity-modulated radiation therapy, outcome | 1 Comment »
Two new studies reported at the American Society for Radiation Oncology (ASTRO) annual meeting yesterday discuss the potential of shorter courses of “hypofractionated” radiation therapy in the treatment of localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: hypofractionated, outcome, radiation, risk | 1 Comment »
Today’s news reports include information on:
Filed under: Drugs in development, Management, Treatment | Tagged: AZD0530, conformal beam, hypofractionated, old, radiotherapy, raduical prostatectomy, standard, young | Leave a comment »
Todays news reports adddress:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: biopsy, core, EBRT, external beam radiation therapy, hormone therapy, hospital, hypofractionated, IMRT, radical prostatectomy, sexual function, surgeon, volume | Leave a comment »
Today’s news reports deal with items on:
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: arc, bitter melon, focal therapy, hypofractionated, intensity-modulated, radiotherapy, reconstruction, sulforaphane, urinary tract | Leave a comment »
Today’s news deals with such items as:
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: Apoptone, cystoprostatectomy, HE3235, hypofractionated, IMRT, photodynamic therapy | Leave a comment »
